Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
Alejandro A. Rabinstein, MD, FAHA
Richard E. Pratley, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
New Frontiers in the Treatment of DMD Across the Age Spectrum
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
High-Efficacy DMTs: Transforming MS Care
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Z. Obeidat, MD, PhD
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
From Pathology to Practice: The Role of Inflammation in MS Pathology
Balancing Act: Immune Reconstitution vs Immune Suppression
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Examining Emerging Gut Microbiota Biomarkers for MS
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.